What is SCOPE?

SCOPE, or Supporting Collaborative Care to Optimize Psychosocial Engagement in the Cancer Setting, is a research study that tests new technologies to enhance the delivery of collaborative care for people with cancer.

 

What is Collaborative Care?

Collaborative Care is a team-based approach to caring for the whole you. It coordinates cancer treatment with treatment of other symptoms that often accompany a diagnosis of cancer, such as anxiety and low mood, loss of interest in usual activities, difficulties with sleep, low energy, and poor concentration. Collaborative Care helps you better tolerate your cancer treatment and manage through this challenging period.

 

SCOPE Technology

The technologies used in SCOPE are intended to help patients and their Clinical Social Workers partner together to share information and better coordinate care. Through SCOPE, we hope to learn if these new technologies help improve patient care, reduce distressing symptoms, and improve quality of life. If these tools are helpful, we will make them widely available to people diagnosed with cancer.

 

Where and When?

SCOPE is a multi-site study that recruits from six cancer clinics in western Washington. These sites include Fred Hutch South Lake Union, Fred Hutch UW-Northwest, Fred Hutch Peninsula, MultiCare Regional Cancer Center Tacoma, MultiCare Auburn, and MultiCare Gig Harbor. The study started in 2022 and will end in 2025.

 

Who can Participate?

Patients at one of the study sites and referred by their Clinical Social Worker.

 

How is SCOPE funded?

SCOPE is funded by a grant from the National Cancer Institute (NCI-R01CA244171).